Showing results 1 - 16 of 182 for Sharma
stjude.org/directory/s/akshay-sharma.html
Akshay Sharma, MBBS, Pediatric Hematology-Oncology Fellowship Program, St. Jude Children's Research Hospital
stjude.org/media-resources/news-releases/2020-medicine-science-news/hematologist-akshay-sharma-r...
Akshay Sharma, MBBS, of St. Jude is the recipient of a 2020 Scholar Award from the American Society of Hematology (ASH).
stjude.org/media-resources/news-releases/2021-medicine-science-news/covid-19-poses-serious-risk-...
St. Jude scientists are discovering that children and adults who receive bone marrow transplants should make COVID-19 prevention a priority.
stjude.org/research/progress/2021/covid-and-bone-marrow-transplant-increased-risk.html
Research points to bone marrow transplant patients having the highest risk for severe complications from a COVID infection. Here’s what that means.
stjude.org/care-treatment/clinical-trials/scdhct-sickle-cell-disease.html
This study tests a reduced intensity conditioning-based method to lessen side effects of hematopoietic cell transplant in patients with sickle cell disease.
stjude.org/care-treatment/clinical-trials/casper-sickle-cell-disease.html
Learn about a Phase I/II clinical trial using CRISPR-Cas9 gene editing technology to restore fetal hemoglobin production in patients with severe SCD.
stjude.org/care-treatment/clinical-trials/casperkid-sickle-cell-disease.html
A clinical trial of CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (exa-cel) in Children with Severe Sickle Cell Disease. Learn more.
stjude.org/care-treatment/clinical-trials/bheem-sickle-cell-disease.html
A clinical trial studying Base Edited CD34+ Human Hematopoietic Stem and Progenitor Cells (BEAM-101) in Patients with Severe Sickle Cell Disease. Learn more.
stjude.org/about-st-jude/stories/promise-magazine/summer-2021/a-gentler-approach-to-transplants....
Using a gentler chemotherapy and radiation conditioning regimen, the Sickle Cell Disease Hematopoietic Cell Transplantation (SCDHCT) study aims to cure children with severe sickle cell disease and reduce side effects and subsequent health issues.
stjude.org/about-st-jude/stories/promise-magazine/spring-2019/secrets-beneath-the-surface.html
What hidden hazards lie beneath the surface of genome editing? One scientist develops tools to make detailed maps of uncharted territory.
stjude.org/care-treatment/clinical-trials/scdstemm-sickle-cell-disease.html
This study aims to see if motixafortide is safe and helps increase collection of stem cells in adults with sickle cell disease. Learn more about the study.
stjude.org/research/progress/2023/collaborating-for-care-developing-a-new-global-standard-for-si...
Discover how St. Jude researchers collaborate with other experts to influence sickle cell disease treatment and improve patient care globally.
stjude.org/media-resources/expert-topics/bone-marrow-transplantation-experts-and-information.htm...
Find experts who can discuss bone marrow transplantation and cellular therapies research and clinical outcomes.
stjude.org/research/progress/2024/bone-marrow-transplantation-for-sickle-cell-disease-improves-m...
Learn about St. Jude research showing that bone marrow transplantation to treat sickle cell disease can improve heart damage such as myocardial fibrosis.
stjude.org/media-resources/expert-topics/genome-editing-experts-and-information.html
Find experts who can discuss gene editing and genetic engineering to treat pediatric cancer and sickle cell disease.
stjude.org/directory/s/ali-suliman.html
Ali Y. Suliman, MD, MSc, St. Jude Faculty, Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children's Research Hospital